Opinion
AHA Comments on HRSA’s RFI Re: 340B Rebate Model Pilot Program – HHS Docket No. HRSA-2026-03042
The American Hospital Association's initial comment on the Health Resources and Services Administration’s (HRSA) request for information regarding a 340B Rebate Model Pilot Program.
Good intentions alone are not enough in 340B. Let’s get informed. The good news is that the growing national scrutiny of how the 340B program operates should be seen not as a threat, but as an ...
Hospitals and clinics in Michigan participating in a federal drug discount program are marking up medications and shifting costs onto public employee health plans, according to ...
A federal judge on Monday temporarily blocked the U.S. administration’s planned 340B Rebate Model Pilot Program, finding that regulators likely failed to meet basic administrative law requirements ...
Drug companies are more likely than hospitals to violate 340B regulations, according to a recent American Hospital Association report. The 340B Drug Pricing Program has been under constant attack on ...
Some hospitals are buying life-saving medications for pennies, then charging low-income patients, including many with disabilities, hundreds of dollars for these drugs. They do it every day under a ...
340B is a tremendous federal program that ought to be fixed — by the federal government. A state initiative would make things worse. Credit: Getty Images. When something isn't working, we look to our ...
Nonprofit hospitals aren’t abusing the 340B pricing program. The fault lies with profit-taking drugmakers.
The 340B program, once a lifeline for underserved communities, has become a case study in crony capitalism. Designed to help hospitals serving low-income patients by offering discounted prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results